Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs202001770 | chr13:114170881 | A/C | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs202080412 | chr8:53841925 | TC/T | 0.000433 | 173 | 24.47 | 27.27 | 6.1 | KM Plot |
PCPG | rs202089630 | chr2:118564601 | C/T | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs202133746 | chr2:61445299 | GT/G | 8.88E-5 | 174 | 21.95 | 30.93 | 10.3 | KM Plot |
PCPG | rs202191623 | chr2:217052023 | A/ATT | 7.36E-5 | 175 | 25.17 | 28.3 | 2.93 | KM Plot |
PCPG | rs202234710 | chr2:176196459 | CAAA/C | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs202236966 | chr2:24335878 | A/T | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs2024246 | chr14:74625576 | C/T | 3.67E-12 | 178 | 25.28 | 27.27 | 10.3 | KM Plot |
PCPG | rs2024598 | chr6:131711572 | T/C | 7.3E-6 | 174 | 15.33 | 28.3 | 24.7 | KM Plot |
PCPG | rs2024599 | chr6:131711658 | C/T | 7.3E-6 | 174 | 15.33 | 28.3 | 24.7 | KM Plot |
PCPG | rs2024600 | chr6:131711753 | C/T | 0.000241 | 175 | 15.33 | 27.78 | 24.7 | KM Plot |
PCPG | rs2028354 | chr2:209984535 | G/T | 1.15E-9 | 178 | 19.87 | 24.3 | 26.57 | KM Plot |
PCPG | rs2029474 | chr10:69751813 | G/A | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs2036453 | chr4:78948421 | G/A | 0 | 176 | 2.93 | 25.87 | 25.28 | KM Plot |
PCPG | rs2037092 | chr3:80573964 | T/C | 6.58E-5 | 177 | 19.53 | 24.03 | 27.2 | KM Plot |